miércoles, 22 de febrero de 2012

NOTES from NCI Cancer Bulletin for February 21, 2012 - National Cancer Institute

National Cancer Advisory Board to Meet Next Week

The National Cancer Advisory Board (NCAB) will meet February 27–28 in Bethesda, MD. The agenda is available online, and the proceedings will be broadcast live online.
Presentations include a report from NCI leadership, as well as updates on the President’s Cancer Panel from Dr. Barbara Rimer and cooperative group reorganization from Dr. Jeff Abrams.
An archived videocast will be posted a few days after the meeting. Videocasts of past meetings are available here.

Director's Consumer Liaison Group to Discuss Drug Shortages, Advocate Engagement

The NCI Director's Consumer Liaison Group (DCLG) will hold its first meeting of the new year February 29–March 1 in Bethesda, MD. The agenda, which will be posted soon, includes presentations on understanding cancer drug shortages and advocate engagement at NCI. The meeting is open to the public.
The DCLG provides informed, non-scientific perspectives to the NCI director on promoting research outcomes that are in the best interest of cancer patients. Specifically, DCLG members focus on identifying new approaches, promoting innovation, recognizing unforeseen risks or barriers, and identifying unintended consequences that could result from NCI decisions or actions.
The group also provides insight into enhancing input, optimizing outreach, and promoting strong collaborations, all with respect to non-scientist stakeholders, in the interest of meeting common institute and community goals.

New Clinical Trials Portal and Apps Available

Screenshot of NIH Clinical Research Trials and You
A new portal, NIH Clinical Research Trials and You, provides information about the risks and benefits of taking part in a clinical trial, how to find a trial, and questions to ask when considering participation in a trial. The site also features stories from researchers and volunteers who have participated in clinical trials and downloadable materials for professionals interested in raising awareness about trials.
In a related effort, NCI's Center for Cancer Research (CCR) recently launched NCITrials@NIH Exit Disclaimer, a free application (app) for the iPhone, iPod touch, and iPad that provides mobile access to CCR's list of cancer clinical trials. The app enables oncologists, patients, and families to find and share information about NCI-sponsored clinical trials at CCR. The app allows users to search more than 150 clinical trials, save pages as favorites, and share information via Twitter and e-mail.
In addition, the Centers for Disease Control and Prevention (CDC) has also launched its own free iPad app, which allows users to access a wealth of CDC resources, including information on cancer prevention and screening.

NCI Cancer Bulletin for February 21, 2012 - National Cancer Institute: - Enviado mediante la barra Google

No hay comentarios:

Publicar un comentario